Objective Myocardial infarction (MI) is one of the leading causes of death in the world. Early
myocardial reperfusion improves acute MI survival. Bioflavonoid quercetin is known to have …

Objectives: Although significant progress has been made in treatment of patients with acute
coronary syndromes (ACS) sometimes outcomes remain unsatisfactory even after early …

2152 Multicenter randomized clinical trial of the efficacy and safety of intravenous quercetin in
patien Page 1 Abstract: 2152 Multicenter randomized clinical trial of the efficacy and safety of …

Conclusion: Assessment of endogenous fibrinolysis can identify patients with STEMI who
remain at high cardiovascular risk despite PPCI and DAPT. Further studies are needed to …

Background: At present, there is no effective therapy for preventing myocardial ischemia
reperfusion injury (MIRI), and it is inevitable. The methods how to effectively decrease MIRI …

Myocardial infarction (MI) is one of the leading causes of death in the world. Epidemiological
studies have shown that dietary flavonoids are inversely related to cardiovascular morbidity …

Objective: Quercetin is an important member of dietary flavonoid family and widely present
in red wine and Mediterranean diet. The major objective of the this study is to evaluate the …

Background: Following an acute coronary syndrome, patients display an elevated
inflammatory profile, promoted in part by cellular senescence. For patients requiring a …

The aim: The aim of our research was to study the effect of quercetin on parameters of
central hemodynamics and myocardial ischemia in patients with stable coronary heart …

Quercetin is a plant-derived bioflavonoid with potentially beneficial effects on the
cardiovascular system. Studies focused on the efficiency of flavonoids against ischemia …